{
    "2019-11-20": [
        [
            {
                "time": "",
                "original_text": "药明康德涨近3%暂两连扬，破顶兼再次晋身红底股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "涨近3%",
                        "两连扬",
                        "破顶",
                        "红底股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【药明康德】大幅拉升0.61%，股价创近2个月新高",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大幅拉升",
                        "0.61%",
                        "2个月新高"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "英派药业CEO包骏博士：“合成致死”抗癌，大有可为！",
                "features": {
                    "keywords": [
                        "英派药业",
                        "CEO",
                        "包骏",
                        "合成致死",
                        "抗癌"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}